Skip to content
stoqly

Loews

L NYSE Multi-line Insurance Financials FY2016–FY2025

Loews' revenue rose 5.4% to $18.5 billion in fiscal 2025. Its net margin was 9.0%, up from 8.1% a year earlier. Free cash flow was $2.7 billion, up 12.8%. It paid out $858 million in dividends and buybacks, 32% of free cash flow. The diluted share count fell 5.2%.

Last close Β· Oct 23, 2026

$112.01

1.5%
Revenue Total sales reported in the income statement.
$18.5B
5.4% vs prior year
Operating margin Operating income as a share of revenue.
β€”
Net income Profit after all expenses, interest and tax.
$1.7B
17.9%
Free cash flow Cash from operations minus capital spending.
$2.7B
12.8%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
9.5%
0.8 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$23.0B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
13.7x
On $8.16 EPS (TTM)

What Loews does

Loews is a holding company, which means it owns other businesses rather than selling products itself. Its main businesses are CNA Financial, a commercial property and casualty insurer; Boardwalk Pipelines, which transports and stores natural gas, natural gas liquids and other hydrocarbons; and Loews Hotels, which operates a chain of hotels. It also owns part of Altium Packaging, which makes rigid plastic packaging.

Loews reports four segments: CNA, Boardwalk Pipelines, Loews Hotels and Corporate. Loews owns about 92% of CNA, and CNA made up 81.2% of Loews' consolidated revenue in 2025. CNA sells coverages such as professional and management liability, surety bonds, warranty products and standard commercial property and casualty insurance. It sells them through independent agents and brokers to businesses, professionals and other groups, in the United States, Canada, the United Kingdom and Europe.

Boardwalk Pipelines and Loews Hotels are wholly owned. Loews owns about 53% of Altium Packaging, which it does not consolidate in its results. Loews says CNA competes with a large number of stock and mutual insurance companies on price and service.

Legal name
LOEWS CORP
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Feb 10, 2026
Accession Β· CIK
0000060086-26-000008
0000060086

Revenue and margins

Loews had $18.5B of revenue in fiscal 2025, up 5.4% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 17.1% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $2.7B in fiscal 2025, 14.6% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Loews returned $858M to shareholders in fiscal 2025, 32% of free cash flow. The diluted share count fell 5.2%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Loews yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of βˆ’$3.0B and divides by 209.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

β€”

Reference multiples: today 13.7x Β· peers 14.2x Β· sector 13.7x.

Balance sheet

Cash, debt and the ratios that show how comfortably Loews can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $5.5B$5.4B$4.8B$5.1B$6.5B
Debt incl. finance leases $9.1B$9.0B$9.0B$8.9B$9.5B
Net debt / EBITDA 1.2x1.8x1.5x1.3x0.9x
Debt / equity 0.5x0.6x0.6x0.5x0.5x
Interest coverage 6.1x4.0x6.3x5.3x6.2x
Total assets $81.6B$75.6B$79.2B$81.9B$86.3B
Total liabilities $62.5B$60.4B$62.7B$64.0B$66.7B
Shareholders' equity $17.8B$14.3B$15.7B$17.1B$18.7B
Net debt (βˆ’ = net cash) $3.6B$3.6B$4.2B$3.8B$3.0B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$1.1M

1 insider

Sold, 12 months

$31.3M

5 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
May 29, 2026 Dino RobustoDirector Bought 5,000 $104.74 $0.5M Form 4
May 5, 2026 Dino RobustoDirector Bought 5,000 $105.44 $0.5M Form 4
Mar 12, 2026 Andrew H TischDirector Emeritus Sold 50,000 $108.68 $5.4M Form 4
Mar 11, 2026 Andrew H TischDirector Emeritus Sold 50,000 $108.81 $5.4M Form 4
Feb 17, 2026 Mark S SchwartzV.p., C.A.O. and Treasurer Sold 3,150 $110.00 $0.3M Form 4
Feb 13, 2026 Andrew H TischDirector Emeritus Sold 50,000 $108.87 $5.4M Form 4
Feb 12, 2026 Andrew H TischDirector Emeritus Sold 50,000 $110.27 $5.5M Form 4
Feb 10, 2026 Ann E BermanDirector Sold 1,922 $110.16 $0.2M Form 4
Feb 10, 2026 Marc A AlpertSr. VP, Gen. Coun. & Secy. Sold 3,495 $109.87 $0.4M Form 4
Dec 15, 2025 Andrew H TischDirector Emeritus Sold 50,000 $105.07 $5.3M Form 4
Dec 11, 2025 Richard Waldo ScottSVP & Chief Investment Officer Sold 1,000 $104.74 $0.1M Form 4
Dec 4, 2025 Andrew H TischDirector Emeritus Sold 30,000 $104.81 $3.1M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive βœ“ βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ“ βœ• βœ“
Cash from operations exceeds net income βœ“ βœ“ βœ“
Debt fell relative to assets βœ• βœ“ βœ•
Current ratio rose β€” β€” β€”
Share count didn't rise βœ“ βœ“ βœ“
Gross margin rose β€” β€” β€”
Revenue rose relative to assets βœ“ βœ“ βœ“
F-score β€” / 9β€” / 9β€” / 9
Accruals ratio βˆ’3.2%βˆ’2.0%βˆ’1.9%
Altman Z'' β€”β€”β€”

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Loews L $23.0B 5.4% β€” 14.6% 9.5% 13.7x β€”
Assurant AIZ $14.2B 7.9% β€” 12.5% 17.5% 13.6x β€” Compare β†’
American International Group AIG $43.4B βˆ’1.8% β€” β€” 9.3% 14.9x β€” Compare β†’
American Financial Group AFG $12.5B βˆ’1.8% 13.1% β€” 17.8% 13.2x β€” Compare β†’
Corebridge Financial CRBG $15.5B βˆ’1.2% β€” β€” β€” 21.5x β€” Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $13.1B $13.7B $14.1B $14.9B $12.6B $14.7B $14.0B $15.9B $17.5B $18.5B
Gross profit $12.8B $13.4B $13.1B $13.8B β€” β€” β€” β€” β€” β€”
Interest expense $536M $646M $574M $591M $515M $424M $378M $376M $441M $437M
Pretax income $936M $1.6B $834M $1.1B βˆ’$1.5B $2.2B $1.1B $2.0B $1.9B $2.3B
Income tax $220M $170M $128M $248M βˆ’$173M $475M $223M $451M $380M $511M
Net income $654M $1.2B $636M $932M βˆ’$931M $1.6B $822M $1.4B $1.4B $1.7B
Diluted EPS $1.93 $3.45 $1.99 $3.07 βˆ’$3.32 $6.00 $3.38 $6.29 $6.41 $7.97
Diluted shares 0.34B 0.34B 0.32B 0.30B 0.28B 0.26B 0.24B 0.23B 0.22B 0.21B
Cash flow
Cash from operations $2.3B $2.6B $4.2B $1.7B $1.7B $2.6B $3.3B $3.9B $3.0B $3.3B
Capital expenditure $1.5B $1.0B $995M $1.0B $710M $482M $660M $686M $632M $579M
Free cash flow $803M $1.6B $3.2B $700M $1.0B $2.1B $2.7B $3.2B $2.4B $2.7B
Depreciation and amortization $841M $854M $880M $898M $673M $503M $509M $534M $580M $607M
Stock-based compensation $32.0M $33.0M $35.0M $37.0M $37.0M $33.0M $34.0M $36.0M $39.0M $41.0M
Acquisitions $79.0M $1.2B $37.0M $257M $58.0M $0.0M $0.0M $401M $0.0M $0.0M
Share buybacks $134M $216M $1.0B $1.1B $923M $1.1B $729M $849M $608M $806M
Dividends paid $84.0M $84.0M $80.0M $76.0M $70.0M $65.0M $61.0M $57.0M $55.0M $52.0M
Dividends and buybacks $218M $300M $1.1B $1.1B $993M $1.2B $790M $906M $663M $858M
Balance sheet
Cash and short-term investments $5.1B $5.1B $4.3B $5.0B $5.2B $5.5B $5.4B $4.8B $5.1B $6.5B
Total debt $10.8B $11.5B $11.4B $11.5B $10.1B $9.1B $9.0B $9.0B $8.9B $9.5B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Inventory $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Property and equipment, net $15.2B $15.4B $15.5B $15.6B $10.5B $9.9B $10.0B $10.7B $10.7B $10.7B
Total assets $76.6B $79.6B $78.3B $82.2B $80.2B $81.6B $75.6B $79.2B $81.9B $86.3B
Total liabilities $53.2B $55.0B $56.9B $60.3B $61.1B $62.5B $60.4B $62.7B $64.0B $66.7B
Shareholders' equity $18.2B $19.2B $18.5B $19.1B $17.9B $17.8B $14.3B $15.7B $17.1B $18.7B
Margins
Gross margin 97.9% 97.8% 93.4% 92.8% β€” β€” β€” β€” β€” β€”
EBITDA margin 17.7% 22.4% 16.3% 17.5% βˆ’2.2% 21.1% 14.3% 18.3% 16.5% 18.0%
Net margin 5.0% 8.5% 4.5% 6.2% βˆ’7.4% 10.7% 5.9% 9.0% 8.1% 9.0%
FCF margin 6.1% 11.4% 22.9% 4.7% 8.2% 14.6% 18.9% 20.3% 13.7% 14.6%
Returns
Return on capital 3.9% 6.6% 4.0% 4.7% βˆ’3.0% 9.4% 6.0% 9.3% 8.7% 9.5%
Return on equity 3.7% 6.2% 3.4% 5.0% βˆ’5.0% 8.8% 5.1% 9.5% 8.6% 9.3%
Return on assets 0.9% 1.5% 0.8% 1.2% βˆ’1.2% 1.9% 1.1% 1.9% 1.8% 2.0%
Growth
Revenue growth βˆ’2.3% 4.8% 2.4% 6.2% βˆ’15.7% 16.5% βˆ’4.2% 13.2% 10.1% 5.4%
Net income growth 151.5% 78.0% βˆ’45.4% 46.5% βˆ’199.9% β€” βˆ’47.4% 74.5% βˆ’1.4% 17.9%
EPS growth 168.1% 78.8% βˆ’42.3% 54.3% βˆ’208.1% β€” βˆ’43.7% 86.1% 1.9% 24.3%
FCF growth βˆ’59.7% 94.2% 107.0% βˆ’78.3% 47.9% 106.9% 24.0% 21.4% βˆ’25.7% 12.8%
Share count change βˆ’6.7% βˆ’0.2% βˆ’5.2% βˆ’5.2% βˆ’7.6% βˆ’7.2% βˆ’6.5% βˆ’6.4% βˆ’3.2% βˆ’5.2%
Financial health
Net debt / EBITDA 2.5x 2.1x 3.1x 2.5x β€” 1.2x 1.8x 1.5x 1.3x 0.9x
Debt / equity 0.6x 0.6x 0.6x 0.6x 0.6x 0.5x 0.6x 0.6x 0.5x 0.5x
Interest coverage 2.8x 3.5x 2.5x 2.9x βˆ’1.8x 6.1x 4.0x 6.3x 5.3x 6.2x
Capital allocation
Capex / revenue 11.1% 7.5% 7.1% 7.0% 5.6% 3.3% 4.7% 4.3% 3.6% 3.1%
Stock comp / revenue 0.2% 0.2% 0.3% 0.3% 0.3% 0.2% 0.2% 0.2% 0.2% 0.2%
Payouts / FCF 27.2% 19.2% 34.3% 161.0% 95.9% 56.1% 29.8% 28.1% 27.7% 31.8%
Quality scores
Accruals ratio βˆ’2.1% βˆ’1.8% βˆ’4.5% βˆ’1.0% βˆ’3.3% βˆ’1.3% βˆ’3.2% βˆ’3.2% βˆ’2.0% βˆ’1.9%

Source: SEC EDGAR XBRL filings (CIK 0000060086). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open